Dr James Price appointed as director of infection prevention and control

Dr James Price has been appointed as Imperial College Healthcare's new director of infection prevention and control (DIPC).

James is a consultant in infection prevention and control and antimicrobial stewardship. He joined the Trust in 2019 having completed his infectious diseases and microbiology training at Brighton & Sussex University Hospital NHS Trust.

James will take over from Professor Alison Holmes, who stepped down after being in post for over 15 years. She will now focus more on her other academic roles and in supporting applied research within the Trust.

Professor Julian Redhead, medical director of Imperial College Healthcare, said:

“I am really grateful to Alison for all her hard work and commitment to the Trust. During her tenure we have seen real improvements in infection prevention and control, and I look forward to continuing this progress with James to make our services even safer for both patients and staff.

"The role of the director of infection prevention and control has never been more important than now, in the Covid-19 era, and I am really pleased that James will be bringing his expertise and enthusiasm to the role. Since joining the Trust, James has provided expert support and guidance to teams across the organisation and has been a key part of our response to the pandemic, including taking the lead on developing our hospital-onset Covid-19 infection surveillance system. As well as heading up the day-to-day work of the infection prevention and control and antimicrobial stewardship service, James will be working across the trust and the sector to implement the latest tools and applied research and procedures, so that we continue to improve the quality of patient care.”

Dr Price said: “I joined the Trust just before the pandemic and the importance of infection prevention and control has been vital in keeping our patients and staff safe. Continuing on from Alison’s huge achievements, I hope to build on the fantastic progress we’ve made as an organisation so that good infection prevention and control practice and antimicrobial stewardship becomes a positive legacy of Covid-19.”